| Literature DB >> 29903984 |
Gethin H Evans1, Lewis Mattin2, Isabelle Ireland3, William Harrison4, Adora M W Yau5, Victoria McIver6, Tristan Pocock7, Elizabeth Sheader8, Lewis J James9.
Abstract
Whey protein is a commonly ingested nutritional supplement amongst athletes and regular exercisers; however, its role in post-exercise rehydration remains unclear. Eight healthy male and female participants completed two experimental trials involving the ingestion of 35 g of whey protein (WP) or maltodextrin (MD) at the onset of a rehydration period, followed by ingestion of water to a volume equivalent to 150% of the amount of body mass lost during exercise in the heat. The gastric emptying rates of the solutions were measured using 13C breath tests. Recovery was monitored for a further 3 h by the collection of blood and urine samples. The time taken to empty half of the initial solution (T1/2) was different between the trials (WP = 65.5 ± 11.4 min; MD = 56.7 ± 6.3 min; p = 0.05); however, there was no difference in cumulative urine volume throughout the recovery period (WP = 1306 ± 306 mL; MD = 1428 ± 443 mL; p = 0.314). Participants returned to net negative fluid balance 2 h after the recovery period with MD and 3 h with WP. The results of this study suggest that whey protein empties from the stomach at a slower rate than MD; however, this does not seem to exert any positive or negative effects on the maintenance of fluid balance in the post-exercise period.Entities:
Keywords: albumin; exercise; fluid balance; gastric emptying; maltodextrin; recovery; rehydration; whey protein
Mesh:
Substances:
Year: 2018 PMID: 29903984 PMCID: PMC6024862 DOI: 10.3390/nu10060769
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1(a) Half emptying time (T1/2) and time of maximum emptying rate (Tlag) (mins) during the maltodextrin (MD) and whey protein (WP) trials. “*” indicates a significant difference (p < 0.050) between trials. (b) DOB values during the maltodextrin (MD) and whey protein (WP) trials. “*” indicates significantly elevated time points (p < 0.05) from pre-ingestion for the MD trial, “#” indicates significantly elevated time points (p < 0.050) from pre-ingestion for the MD and WP trials and “^” indicates a significant difference (p < 0.050) between the MD and WP trials at a time point.
Figure 2(a) Individual data for T1/2 and (b) Tlag during the maltodextrin (MD) and whey protein (WP) trials.
Figure 3(a) Urine volume (mL) produced at each time point during the maltodextrin (MD) and whey protein (WP) trials. “*” indicates a significantly different time point (p < 0.050) from post-exercise value for the MD and WP trials. (b) The net fluid balance (mL) at each time point for the MD and WP trials. “*” indicates a significantly different time point (p < 0.050) from the pre-exercise value for the MD and WP trials, and “#” indicates significantly different time point (p < 0.050) from the pre-exercise value for the MD trial only.
Figure 4(a) Change in plasma volume (%) from post-exercise time points during the maltodextrin (MD) and whey protein (WP) trials. (b) The serum osmolality (mosm/kg) at each time point for the MD and WP trials. “*” indicates significantly difference (p < 0.050) from post-exercise time point for the MD and WP trials. (c) Serum albumin concentration (g/L) at each time point during the MD and WP trials.